BioSpace News Archive

Catalyst Pharmaceuticals, Inc. today reported that the District Court which heard Catalyst’s Lawsuit against the FDA has entered summary judgment in favor of Catalyst.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel detects Omicron COVID-19 subvariants BA.1, BA.2, and BA.3.

Global Blood Therapeutics, Inc. announced that on February 1, 2022, the compensation committee of GBT’s board of directors granted 21 new employees options to purchase an aggregate of 33,290 shares of the company’s common stock with a per share exercise price of $29.33 and restricted stock units for an aggregate of 80,100 shares of the company’s common stock.

EUROIMMUN assay used to detect previous dengue virus infection will help children and adolescents gain access to vaccine.

Incyte announced that it will present at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 11:20 a.m. ET.

Worldwide Clinical Trials, Inc., the industry’s leading global, midsize, full-service contract research organization, announced its partnership with Ledger Run, Inc., an innovative technology company.

Curie Therapeutics Inc. today announced the appointment of Kapil Dhingra, MBBS, to its Board of Directors.

EVERSANA today announced a strategic partnership with Integra Connect, LLC to create a comprehensive longitudinal oncology patient database.

UroGen Pharma Ltd. today announced the initiation of its Phase 3 ENVISION study of UGN-102 (mitomycin) for intravesical solution, in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC).

The Canadian Neuromuscular Disease Registry and Amylyx Pharmaceuticals (NASDAQ: AMLX) today announced they are partnering on a real‐world evidence generation initiative for Amylyx’ novel investigational therapy AMX0035.